Thanks everyone for making part of Paraguay SOLACI Sessions 2022!

We have reached the end of SOLACI Sessions 44th edition. 

We have enjoyed 2 days of intense scientific activities with multiple educational symposia, case study discussions, theoretical and practical approaches to issues of interest in interventional cardiology and fruitful knowledge exchange between prestigious colleagues from Paraguay and Latin America. 

¡Gracias a todos por ser parte de las Jornadas SOLACI Paraguay 2022!

With over 200 registered attendees and more than 750 online participants, the 44th edition of SOLACI Sessions have accomplished our mission: to keep integrating, interconnecting, and sharing experiences from different parts of the region, promoting scientific advance and continuous development. 

Day 2 started with the already traditional course for fellow interventionists, when a panel of renowned interventionists assess and comment on complex case studies sent by young promising hemodynamics specialists from all corners of Latin America. The winners of this edition were Drs. Juan Ignacio Mayol (presenting “Transseptal transcatheter mitral valve-in-valve”) and Claudia González Zuñiga (presenting “Snare technique for retrograde wire externalization in right coronary artery CTO angioplasty”).

Juan Ignacio Mayol & Claudia González Zuñiga, winners of the young cardiologists contest.

We then moved on to “one case, one lesson”, when different senior interventional cardiologists share their experience on complex challenging cases. 

Later, the long-expected MIL Group presented 4 TAVR interventions performed in Paraguay together with colleagues from private and public institutions. This has become a milestone in the group’s history, showing how far they have come, and also SolSOLACI, which took part in one of the procedures. 

Finally, the last sessions of this important event took place: a round table on TAVR and another on structural intervention. 

It was a pleasure for SOLACI to be able to visit our sister country Paraguay after 2 years of pandemic, and to keep advancing knowledge, integration and exchange between colleagues, to further improve patient quality of life across our beautiful continent. 

We will meet again in México for SOLACI-SOCIME 2022 (on August 4 thru 6) and later at Colombia Session 2022 (October 6, 7 and 8)!


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Check out the best images of the El Salvador 2024 Sessions

Review the highlights of the XLIX SOLACI Regional Sessions held at the Intercontinental Hotel in San Salvador, El Salvador between November 7 and 8,...

The El Salvador 2024 Sessions are coming soon

The XLIX SOLACI 2024 Regional Sessions (17th Central America & the Caribbean) are approaching, and will take place in the city of San Salvador (El Salvador)....

Check out the best images of the Arequipa 2024 Sessions

Review the highlights of the XVIII SOLACI Regional Sessions held at the Hanan Hotel in Arequipa, Peru between October 3 and 4, 2024. <!-- wp:tw/bwg...

Virtual Event SOLACI-Medtronic | The Visible Heart Lab

We invite you to participate in a new virtual activity organized in collaboration with Medtronic, focused on "The Visible Heart Lab" and dedicated to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....